HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 23 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -33.3% | 3,327 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 3,327 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -72.2% | 3,327 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -5.3% | 3,327 | 0.0% | 0.00% | – |
| Q3 2021 | $19,000 | 0.0% | 3,327 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | +5.6% | 3,327 | 0.0% | 0.00% | – |
| Q1 2021 | $18,000 | +12.5% | 3,327 | 0.0% | 0.00% | – |
| Q4 2020 | $16,000 | – | 3,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|